Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1

Interventions

Metformin 6 Spironolactone 4 ganirelix 3 Progesterone 3 Pioglitazone 2 Ovidrel 2 Methyltestosterone 2 Hydrocortisone 2 Estradiol 2 Cosyntropin 2 Thyrotropin 1 Testosterone 1 Ortho Evra 1 Luteinizing Hormone 1 Leuprolide 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Inositol 1 Flutamide 1 Dexamethasone 1 Contraception 1 Body Mass Index 1 Blood Urea Nitrogen 1 Adrenocorticotropic Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Polycystic Ovary Syndrome × Flutamide × Clear all

NCT04597099 2023-11-02

CRM010

University of Virginia

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡